BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

UBS ASSET MANAGEMENT AMERICAS INC's Holding History (CIK: 0000861177)

Note: Option positions (PUT/CALL) are excluded.

Q1 2024
Shares 47,388,000 Value ($000) $38,810 Avg Close — Range —
Q4 2023
Shares 53,388,000 Value ($000) $45,218 Avg Close — Range —
Q3 2023
Shares 53,388,000 Value ($000) $40,339 Avg Close — Range —